These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23776069)

  • 21. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
    Brosens LA; Iacobuzio-Donahue CA; Keller JJ; Hustinx SR; Carvalho R; Morsink FH; Hylind LM; Offerhaus GJ; Giardiello FM; Goggins M
    Clin Cancer Res; 2005 Jun; 11(11):4090-6. PubMed ID: 15930344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
    Han S; Inoue H; Flowers LC; Sidell N
    Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Up-regulation of cyclooxygenase-2 by interleukin-1beta in colon carcinoma cells.
    Duque J; Díaz-Muñoz MD; Fresno M; Iñiguez MA
    Cell Signal; 2006 Aug; 18(8):1262-9. PubMed ID: 16326073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Genetic polymorphisms in the promoter region of cyclooxygenase-2 and their association with risk of gastric cancer].
    Zhang XM; Miao XP; Tan W; Sun T; Guo YL; Zhao D; Lin DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Apr; 28(2):119-23. PubMed ID: 16733888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The COX-2 G/C -765 polymorphism may modulate the occurrence of cerebrovascular ischemia.
    Colaizzo D; Fofi L; Tiscia G; Guglielmi R; Cocomazzi N; Prencipe M; Margaglione M; Toni D
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):93-6. PubMed ID: 16479190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A cox-2 promoter-based replication-selective adenoviral vector to target the cox-2-expressing human bladder cancer cells.
    Shirakawa T; Hamada K; Zhang Z; Okada H; Tagawa M; Kamidono S; Kawabata M; Gotoh A
    Clin Cancer Res; 2004 Jul; 10(13):4342-8. PubMed ID: 15240520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional polymorphism (-347 G-->GA) in the E-cadherin gene is associated with colorectal cancer.
    Shin Y; Kim IJ; Kang HC; Park JH; Park HW; Jang SG; Lee MR; Jeong SY; Chang HJ; Ku JL; Park JG
    Carcinogenesis; 2004 Nov; 25(11):2173-6. PubMed ID: 15231691
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of UVB-induced and basal cyclooxygenase-2 (COX-2) expression by apigenin in mouse keratinocytes: role of USF transcription factors.
    Van Dross RT; Hong X; Essengue S; Fischer SM; Pelling JC
    Mol Carcinog; 2007 Apr; 46(4):303-14. PubMed ID: 17186551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celecoxib inhibits the expression of survivin via the suppression of promoter activity in human colon cancer cells.
    Sakoguchi-Okada N; Takahashi-Yanaga F; Fukada K; Shiraishi F; Taba Y; Miwa Y; Morimoto S; Iida M; Sasaguri T
    Biochem Pharmacol; 2007 May; 73(9):1318-29. PubMed ID: 17270149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of cyclooxygenase-1 and -2 expression by targeting the endothelin a receptor in human ovarian carcinoma cells.
    Spinella F; Rosanò L; Di Castro V; Nicotra MR; Natali PG; Bagnato A
    Clin Cancer Res; 2004 Jul; 10(14):4670-9. PubMed ID: 15269139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of PAI-1 promoter 4G/5G polymorphism in healthy Chinese and functional characterization using a luciferase reporter vector.
    Ding Z; Pan JQ
    Ann Hematol; 2005 Mar; 84(3):183-7. PubMed ID: 15309528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
    Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
    Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disruption of Rb/E2F pathway results in increased cyclooxygenase-2 expression and activity in prostate epithelial cells.
    Davis JN; McCabe MT; Hayward SW; Park JM; Day ML
    Cancer Res; 2005 May; 65(9):3633-42. PubMed ID: 15867358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2 polymorphisms and susceptibility to colorectal cancer: a meta-analysis.
    Wang J; Guo X; Zhang J; Song J; Ji M; Yu S; Wang J; Cao Z; Dong W
    Yonsei Med J; 2013 Nov; 54(6):1353-61. PubMed ID: 24142638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
    Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
    PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Strategies to accomplish targeted expression of transgenes in ovarian cancer for molecular therapeutic applications.
    Casado E; Gomez-Navarro J; Yamamoto M; Adachi Y; Coolidge CJ; Arafat WO; Barker SD; Wang MH; Mahasreshti PJ; Hemminki A; Gonzalez-Baron M; Barnes MN; Pustilnik TB; Siegal GP; Alvarez RD; Curiel DT
    Clin Cancer Res; 2001 Aug; 7(8):2496-504. PubMed ID: 11489832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
    Akhtar M; Cheng Y; Magno RM; Ashktorab H; Smoot DT; Meltzer SJ; Wilson KT
    Cancer Res; 2001 Mar; 61(6):2399-403. PubMed ID: 11289104
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclooxygenase-2 expression and prostanoid biogenesis reflect clinical phenotype in human colorectal fibroblast strains.
    Zhu Y; Hua P; Lance P
    Cancer Res; 2003 Jan; 63(2):522-6. PubMed ID: 12543811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squmaous cell carcinoma.
    Upadhyay R; Jain M; Kumar S; Ghoshal UC; Mittal B
    Mutat Res; 2009 Apr; 663(1-2):52-9. PubMed ID: 19428370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclooxygenase-2 overexpression reduces apoptotic susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells.
    Sun Y; Tang XM; Half E; Kuo MT; Sinicrope FA
    Cancer Res; 2002 Nov; 62(21):6323-8. PubMed ID: 12414664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.